Qin Xia
Corporate Officer/Principal at TRANSCENTA HOLDING LIMITED
Profile
Qin Xia is currently the VP-Commercial Planning & Business Development at Transcenta Holding Ltd.
Prior to this, Ms. Xia worked as the Director-Commercial Strategy & Analysis Engagement at Amgen, Inc. from 2005 to 2019, as well as in various managerial roles at Baxter BioScience Corp.
and Bristol Myers Squibb Co. Ms. Xia holds a graduate degree from the University of Southern California, an undergraduate degree from East China Normal University, and an MBA from USC Marshall School of Business.
Qin Xia active positions
Companies | Position | Start |
---|---|---|
TRANSCENTA HOLDING LIMITED | Corporate Officer/Principal | 2020-01-31 |
Former positions of Qin Xia
Companies | Position | End |
---|---|---|
AMGEN INC. | Corporate Officer/Principal | 2019-08-31 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2005-06-30 |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Corporate Officer/Principal | 2004-04-30 |
Training of Qin Xia
East China Normal University | Undergraduate Degree |
University of Prince Edward Island | Graduate Degree |
University of Southern California | Graduate Degree |
USC Marshall School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
TRANSCENTA HOLDING LIMITED | Health Technology |
AMGEN INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private companies | 1 |
---|---|
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Health Technology |
- Stock Market
- Insiders
- Qin Xia